Verapamil in the treatment of hypertension. (Record no. 6166851)

MARC details
000 -LEADER
fixed length control field 01271 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250512201032.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 198109s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0160-2446
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/00005344-198103000-00007
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Anavekar, S N
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19810915
245 00 - TITLE STATEMENT
Title Verapamil in the treatment of hypertension.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of cardiovascular pharmacology
Date of publication, distribution, etc.
300 ## - PHYSICAL DESCRIPTION
Extent 287-92 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Blood Pressure
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hypertension
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pindolol
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Placebos
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Random Allocation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Verapamil
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Christophidis, N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Louis, W J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Doyle, A E
773 0# - HOST ITEM ENTRY
Title Journal of cardiovascular pharmacology
Related parts vol. 3
-- no. 2
-- p. 287-92
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1097/00005344-198103000-00007">https://doi.org/10.1097/00005344-198103000-00007</a>
Public note Available from publisher's website

No items available.